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Abstract 
Objective: To investigate  whether emulsified isoflurane preconditioning could reduce 
lung injury induced by hepatic I/R in rats and its mechanism. 
Materials and methods: 32 pentobarbital-anesthetized Sprague-Dawley rats were equally 
randomized into four groups: laparotomy group (Sham group), hepatic I/R and normal 
saline infusion group (I/R+S group), I/R and lipid vehicle infusion (I/R+V group), or 
I/R and 8% emulsified isoflurane infusion (I/R+E group) at the rate of 8 ml·kg-1·h-1 for 30 
min. Blood supply of the hepatic artery and portal vein to the left and the median liver 
lobes was occluded for 90 min after 30-min washout time. Reperfusion was allowed to 
proceed for 4 h before sacrifice of the animals. Lung injury was observed histologically. 
Neutrophil  infiltration  and  TNF-α  concentration  in  serum  and  lung  were  measured. 
Changes of wet-to-dry weight ratios in lung tissue, ICAM-1 expression and NF-κB activ-
ity in lung after hepatic I/R were determined.  
Results: Compared with I/R+S or I/R+V group, emulsified isoflurane preconditioning 
reduced  hepatic  I/R-induced  lung  histologic  injury  and  inhibited  the  increase  of 
myeloperoxidase (MPO) activity in the lung tissue markedly (5.5±1.37 and 5.22±1.33 vs 
3.81±1.62 U/g, P<0.05). In addition, both serum and lung tissue TNF-α levels were re-
duced  in  I/R+E  group  (104.58±31.40  and  94.60±22.23  vs  72.44±17.28  pg/ml,  P<0.05; 
393.51±88.22 and 405.46±102.87 vs 292.62±74.56 pg/ml, P<0.01). Emulsified isoflurane 
preconditioning  also  inhibited  the  increase  of  ICAM-1  expression  (0.79±0.17  and 
0.84±0.24  vs  0.62±0.21,  P<0.05)  and  NF-κB  translocation  (4.93±0.48  and  4.76±0.57  vs 
4.01±0.86, P<0.05) in the lung tissue markedly. 
Conclusions:  Emulsified  isoflurane  preconditioning  markedly  attenuated  hepatic 
I/R-induced lung injury in rats, which may be hopefully applied to the clinical treatment 
of organ injury caused by hepatic surgery, transplantation or hemorrhagic shock. 
Key words: emulsified isoflurane; inflammation; intercellular adhesion molecule-1; neutrophils; 
nuclear factor-κB; rats; tumor necrosis factor-α  
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Ischemia/reperfusion  (IR)  injury  represents  a 
complex series of events, including release of reactive 
oxygen species, nitric oxide imbalance, cytokine cas-
cades,  neutrophil  accumulation  and  cell  death,  re-
sulting  in  cellular  and  tissue  damage1.  Hepatic  I/R 
injury, which can been seen in various clinical settings 
such as liver transplantation, hepatectomy, and hem-
orrhagic shock, may lead to local and remote organ 
damage2, yet the precise pathogenesis is not fully de-
fined.  Massive  accumulation  of  neutrophils  in  the 
lung, the development of interstitial pulmonary ede-
ma  and  increased  expression  of  proinflammatory 
mediators are major features of lung injury induced 
by hepatic I/R. 
Various  methods,  including  pharmacological 
treatment, gene therapy and ischemia precondition-
ing, have been applied to ameliorate hepatic I/R in-
jury,  with  inspiring  results.  In  1986,  Murry  et  al3 
demonstrated for the first time that intermittent epi-
sodes of ischemia had a protective effect on the myo-
cardium that was later subjected to a sustained bout 
of  ischemia.  A  characteristic  of  ischemic  precondi-
tioning is a cross-tolerance phenomenon. The efficacy 
of  anesthetic  preconditioning  was  first  described  in 
1997 with isoflurane in animals4,5, and later confirmed 
by  several  studies  in  the  brain6,  kidney7  and  liver8. 
Inhaled isoflurane preconditioning was also shown to 
reduce acute lung injury and inflammation induced 
by endotoxin9,10 or I/R11. 
Emulsified isoflurane has been widely studied in 
recent  years,  because  it  was  found  to  eliminate  the 
need  for  specific  ventilatory  circuits,  provide  rapid 
anesthetic  induction and recovery, have remarkable 
hemodynamic  stability12  and  reduce  environmental 
pollution and tissue toxicity. Rao et al13 demonstrated 
that emulsified isoflurane had a myocardial protective 
effect on I/R injury similar to that of inhaled isoflu-
rane.  We  therefore  hypothesized  that  emulsified 
isoflurane preconditioning might also be able to in-
hibit  inflammation  reaction  and  reduce  lung  injury 
induced by hepatic I/R in rats.  
Materials and methods 
Inbred  male  Sprague-Dawley  rats  weighing 
200-250 g (Experimental Animal Center of the Second 
Military Medical University, Shanghai, China) were 
maintained in laminar flow cages in a specific patho-
gen  free  animal  facility,  and  allowed  free  access  to 
standard  laboratory  chow  and  water  before  experi-
ments. This study was approved by the animal care 
committee at the Second Military Medical University 
and all procedures in this experiment were performed 
according to the Guide for the Care and Use of La-
boratory Animals. 
Surgical procedures of hepatic I/R 
A  model  of  segmental  (70%)  hepatic  ischemia 
was  used  as  previously  described14,15.  Rats  were 
anesthetized intraperitoneally with pentobarbital (40 
mg/kg). Body temperature was monitored by a rectal 
probe  and  maintained  at  around  37℃  by  a  heating 
lamp. The right carotid artery was cannulated for ar-
terial blood monitoring and blood-gas analysis, and 
the right jugular vein was cannulated for drug infu-
sion and blood sampling. A midline laparotomy was 
performed,  and  an  atraumatic  clip  was  applied  to 
interrupt the arterial and portal venous blood supply 
to the left and median lobes of the liver. The clip was 
removed 90 min after partial hepatic ischemia to ini-
tiate  hepatic  reperfusion.  Sham  control  rats  under-
went the same protocol  without vascular occlusion. 
Oxygen  was  not  given  during  the  surgery  and 
throughout the experimental period. Rats were killed 
after  4-h  reperfusion,  and  lung  tissues  and  blood 
samples were collected for analysis.  
Preparation of emulsified isoflurane  
The  8%  emulsified  isoflurane  (v/v)  manufac-
tured  by  Huarui  Pharmacy,  Ltd  (Wuxi,  China)  ac-
cording  to  the  procedures  described  previously16,17, 
was kindly bestowed by Prof. Jin Liu from the Labor-
atory of Anesthesiology and Critical Care Medicine, 
West China Hospital, Sichuan University (Chengdu, 
China). Briefly, 1.6 mL liquid isoflurane and 18.4 mL 
30%  Intralipid®  (fat  emulsion  injection,  Sino-Swed 
Pharmaceutical  Corp.  LTD,  China)  was  mixed  in  a 
20-mL  glass  ampoule  and  sealed  using  an  alcohol 
blowtorch. The ampoule was then vigorously shaken 
on a vibrator for 15 min to solubilize isoflurane into a 
lipid  emulsion.  The  emulsified  isoflurane  ampoule 
was opened just before use and the residual drug was 
discarded. Before this experiment, the stability of 8% 
emulsified isoflurane  was  investigated by  gas chro-
matography. There was no change in isoflurane con-
centration  nor  were  lipid  droplets  found  during  6 
months of storage at room temperature. 
Experimental Design 
Group 1. Sham (n=8): animals were subjected to 
anesthesia and laparotomy. 
Group 2. I/R+S (n=8): animals were infused with 
normal saline through the right external jugular vein 
at the rate of 8 ml·kg-1·h-1 for 30 min, and then sub-
jected to 70% hepatic ischemia for 90 min, followed by 




Group 3. I/R + V (n=8): animals were infused 
with lipid vehicle (Intralipid®, 30%) through the right 
external jugular vein at the rate of 8 ml·kg-1·h-1 for 30 
min,  followed  by  a  30-min  wash-out  period  before 
I/R. 
Group 4. I/R + E (n=8): animals were infused 
with emulsified isoflurane through the right external 
jugular vein at the rate of 8 ml·kg-1·h-1 for 30 min as 
Rao described13, followed by a 30-min wash-out pe-
riod before I/R.  
Lung Function 
Before sacrifice of the animals, arterial blood was 
sampled from the right carotid artery for blood gas 
analysis  with  a  blood-gas  analyzer  (GEM  Premier 
3000, Instrumentation Laboratory, USA). 
Histology 
The middle lobe of the right lung was excised for 
histopathology.  Samples  were  fixed  in  10%  neutral 
buffered  formalin,  paraffin  embedded,  sliced  into 
5-µm sections, stained with hematoxylin-eosin (H&E) 
according to standard procedures, and evaluated by 
light-microscopic examination. 
Pulmonary edema  
The extent of lung edema was measured by tis-
sue wet to dry weight ratios. The lower lobe of the 
right lung from each animal was harvested, blotted 
dry,  weighed,  incubated  at  60℃  overnight  and  re-
weighed18. The wet to dry weight ratio was calculated 
by dividing the wet by the dry weight.  
Myeloperoxidase assay 
Myeloperoxidase (MPO), a marker of pulmonary 
neutrophil  accumulation  and  activation,  was  deter-
mined  by  a  modified  method  of  Welborn  et  al19. 
Briefly,  frozen  lung  sample  (200mg)  was  homoge-
nized in 0.01 M KH2PO4 at a ratio of 1:10 weight for 
volume. The pellets were resuspended in 0.5 mL of 
C-TAB  (cetyltrimethylammoniumbromide)  buffer. 
The samples were homogenized, sonicated for 45 s, 
and  subjected  to  one  freeze-thaw  cycle.  MPO  was 
assayed in the supernatant with the H2O2-dependent 
oxidation  of  3,3’,5,5’-tetramethylbenzidine.  Absorb-
ance was read at 650 nm and compared with a linear 
standard  curve  with  sensitivity  to  0.008  U.  Values 
were then divided by the wet weight of the lung tis-
sue. 
Lung tissue and serum tumor necrosis factor-α 
(TNF-α) Assay 
Frozen  lung  tissue  was  homogenized  in  10 
volumes  of  50  mmol/L  phosphate  buffer  (pH  6.0). 
After  centrifugation  at  4,000g,  the  supernatant  was 
frozen at -20℃ and saved for measurement of TNF-α 
level. 2 ml blood obtained from the right jugular vein 
was  centrifuged  at  3,000g  to  get  serum,  which  was 
saved at -20℃ for measurement of TNF-α levels. Lung 
tissue and serum TNF-α levels were measured using a 
commercial  rat  TNF-α  ELISA  kit  (R&D  Systems, 
USA). 
RT-PCR analysis of intercellular adhesion mole-
cule-1 (ICAM-1) mRNA expression in the lung 
ICAM-1  mRNA  from  frozen  lung  tissues  was 
measured  using  semi-quantitative  RT-PCR.  Total 
RNA was extracted from the tissue sample using the 
Trizol  reagent  (Invitrogen,  Life  Technologies)  ac-
cording  to  the  manufacturer’s  protocol.  The  RNA 
concentration  was  determined  by  ultraviolet  light 
absorbance at a wavelength of 260nm. The first-strand 
complementary DNA (cDNA) was synthesized using 
oligo-dT primer and the AMV reverse transcriptase. 
The cDNA products were amplified in 50μl reaction 
volume containing 50 pmol of each primer, 1μl of the 
cDNA reaction mix, 5μl Buffer (10 mmol/L), 1μl of 
each  dNTP  (10mmol/L),  and  3  units  of  Taq  DNA 
polymerase (GIBCO Life Technologies). After 5-min 
initial melting at 95℃, the mixture was amplified for a 
total of 30 cycles with a three-step cycle process that 
began with melting at 95℃ for 45 s, annealing at 60℃ 
for 30 s, and extension at 72℃ for 45 s. The final cycle 
was followed by 5-min soaking at 72℃. The nucleo-
tide  sequences  of  the  PCR  primers  were  5'- 
CTTCAAGCTGAGCGACATTGG  -3'  (forward)  and 
5'- AGCATGAGAAATTGGCTCCGT -3' (reverse) for 
ICAM-1  and  5'-  ACCACAGTCCATGCCATCAC  -3' 
(forward)  and  5'-  TCCACCACCCTGTTGCTGTA  -3' 
(reverse) for GAPDH. The expected size of the ampli-
fied  cDNA  fragments  of  ICAM-1  and  GAPDH  was 
326 and 452 bp, respectively. Ten microliters of each 
RT-PCR were electrophoresed in a 1.5% agarose gel 
and stained with ethidium bromide. The intensity of 
each ICAM-1 mRNA band was quantified by densi-
tometry using a gel documentation and analysis sys-
tem and normalized to values for GAPDH. 
Western blot analysis for nuclear factor-B 
(NF-B) activity 
Nuclear proteins were prepared from lung tis-
sues  according  to  the  modified  protocols  of  previ-
ously  studies20,21.  Briefly,  frozen  liver  tissues  were 
homogenized  in  cold  buffer  A  containing  10mM 
HEPES-KOH, 1.5mM MgCl2, 10mM KCl, 1mM phe-
nylmenthysulfonylfluoride  (PMSF),  1mM  dithio-
threitol(DTT)  and  0.1mM  EDTA.  The  homogenate 
was centrifuged at 450g for 1 min at 4℃. The super-




vortexed for 30 s after addition of 10% NP-40, then 
centrifuged at 5,000g for 3 min at 4℃. The pellet (nu-
clei)  was  resuspended  in  cold  buffer  B  containing 
20mM  HEPES-KOH,  25%  glycerol,  420mM  NaCl, 
1.5mM  MgCl2,  1mM  PMSF,  1mM  DTT,  and  0.1mM 
EDTA,  and  incubated  for  30  min  with  intermittent 
stirring.  The  suspension  was  centrifuged  at  15,000g 
for 10min at 4℃, and the protein concentration was 
determined by Coomassie blue dye-binding assay. An 
equal amount of protein was mixed with the sample 
buffer, separated by 10% SDS-PAGE, and transferred 
to  nitrocellulose  membranes.  The  membrane  was 
blocked for 1 h at room temperature with blocking 
solution (3% nonfat milk in Tris buffered saline with 
Tween 20). Blots were then incubated overnight at 4℃ 
with  mouse  monoclonal  anti-NF-B  p65  antibody 
(Santa  Cruz  Biotechnology,  1:500),  washed  three 
times,  and  incubated  with  a  horseradish  peroxi-
dase-labeled  secondary  antibody  for  1  h  at  room 
temperature.  Immunoreactive  proteins  were  visual-
ized  with  the  use  of  enhanced  chemiluminescence 
detection (Pierce, USA). The protein band density was 
quantified by densitometric techniques and expressed 
as mean relative densitometric units. 
Statistical analysis 
Data were expressed as mean ± SD. The statisti-
cal analysis was carried out using SPSS 13.0 for Win-
dows. All data were analyzed by ANOVA, followed 
by the Student-Newman-Keuls test. P<0.05 was con-
sidered statistically significant.  
Results 
Arterial blood gas analysis 
Compared with sham group, the IR+S and IR+V 
group had significantly lower PaO2 and higher PaCO2 
(P < 0.05). Preconditioning with emulsified isoflurane 
improved  pulmonary  function,  as  indicated  with 
higher PaO2 and lower PaCO2, while pH, HCO2- and 
SpO2 in IR+S and IR+V groups were lower than those 
in sham and IR+E groups, but the difference was not 
statistically significant (P>0.05, Table 1). 
Table 1 Arterial blood gas analysis  
  pH  PO2  PCO2  HCO2-  SPO2 
sham  7.38±0.05  91.38±3.67a  37.25±2.05a  25.56±1.67  97.00±1.07 
IR+S  7.33±0.03  80.50±6.78  44.38±3.81  22.70±2.99  95.50±1.69 
IR+V  7.33±0.06  80.25±9.38  42.38±3.54  23.33±1.50  95.13±1.96 
IR+E  7.39±0.03  89.13±6.51a  37.25±3.96a  25.20±2.07  96.63±1.19 
Data are expressed as mean ± SD. a p <0.05 vs I/R+S group or 
I/R+V group. 
 
Lung histopathology after hepatic I/R 
The  effects  of  emulsified  isoflurane  precondi-
tioning on the histopathological changes of the lungs 
in rats with hepatic I/R are shown in Figure 1.  
 
 
Figure 1: Morphologic changes of the lung. A, sham group: No histologic alteration was observed. B, IR+S group: the 
inflammatory process was observed as represented by infiltration of leukocytes into interstitial and alveolar spaces, 
edema and partial destruction of the pulmonary architecture. C, IR+V group: Similar to IR+S group D, IR+E group: Lung 





Blind analysis was performed on all samples to 
evaluate  pulmonary  architecture,  tissue  edema  for-
mation and infiltration of the inflammatory cells. The 
results were classified into four grades where Grade 1 
represented  normal  histopathology;  Grade  2  mild 
infiltration of neutrophilic leukocytes; Grade 3 mod-
erate  infiltration  of  neutrophilic  leukocytes  with 
perivascular edema formation and partial destruction 
of the pulmonary architecture and Grade 4 dense in-
filtration  of  neutrophilic  leukocyte  associated  with 
abcess  formation  and  complete  destruction  of  the 
pulmonary  architecture.  Pulmonary  histology  was 
normal in sham group (Grade 1, Fig. 1A). In contrast, 
morphological study showed that the lung tissues in 
the saline treated and fat vehicle treated groups were 
severely damaged 90 min after hepatic ischemia and 4 
h  after reperfusion, as represented by marked infil-
tration  of  leukocytes  into  interstitial  and  alveolar 
spaces, edema and partial destruction of the pulmo-
nary architecture (Grade 3, Fig. 1B & 1C), while only 
moderate lung edema, inflammatory cell infiltration 
and  thickening  of  the  alveolar  wall  were  seen  in 
emulsified  isoflurane  preconditioning  group  (Grade 
2,  Fig.  1D),  suggesting  that  lung  injury  induced  by 






Figure 2: Lung tissue W/D weight ratio (n = 8). Emul-
sified isoflurane suppressed the increases of the lung 
W/D ratio significantly, while no similar protective ef-
fect was observed in NS or lipid vehicle preconditioning. 
a p<0.01 vs sham group; 
b p <0.05 vs I/R+S group or I/R+V 
group.  
 
Pulmonary edema after hepatic I/R 
The lung W/D ratio (a parameter of pulmonary 
edema)  increased  significantly  in  the  I/R+S,  I/R+V 
and I/R+E groups compared with that in sham group 
(Fig.  2).  Emulsified  isoflurane  suppressed  the  in-
creases of the lung W/D ratio significantly, while no 
similar protective effect was observed in NS or lipid 
vehicle preconditioning. 
Myeloperoxidase (MPO) activity after hepatic I/R 
Neutrophil recruitment in the lung was assessed 
by measuring tissue MPO content. Lung tissue MPO 
was low in sham rats(1.41±0.51 U/g), but increased to 
5.5±1.37,  5.22±1.33  and  3.81±1.62  U/g  in  I/R+S, 
I/R+V and I/R+E groups 4 h after hepatic reperfusion 
(P<0.01).  MPO  activity  in  I/R+E  was  significantly 





Figure 3: Lung tissue MPO activity (n = 8). Lung tissue 
MPO was low in sham rats and increased in I/R+S, I/R+V 
and I/R+E groups, while MPO activity in I/R+E was sig-
nificantly  lower  than  that  in  I/R+S  or  I/R+V  group. 
a 
p<0.01 vs sham group; 
b p <0.05 vs I/R+S group or I/R+V 
group.  
 
Lung Tissue and Serum TNF-α level after hepatic 
I/R 
Compared  with  sham  group,  both  serum  and 
lung  TNF-α  levels  increased  significantly  in  I/R+S, 
I/R+V  and  I/R+E  groups  4  h  after  reperfusion 
(P<0.05).  Statistic  analysis  showed  that  both  serum 
and lung TNF-α levels in I/R+E group were signifi-
cantly  lower  than  those  of  I/R+S  or  I/R+V 
group(P<0.05), and there was no significant difference 




ICAM-1 mRNA expression in lung  
RT-PCR analysis revealed that ICAM-1 mRNA 
expression  was  hardly  detectable  in  sham  group. 
However, it was up-regulated markedly in the other 
three groups (Fig. 5). Compared with I/R+S or I/R+V 
group, emulsified isoflurane preconditioning reduced 
ICAM-1 mRNA expression significantly. 
NF-B activity in lung 
A  low  level  of  p65  subunit  of  NF-B  was  ob-
served  in  nuclear  extracts  of  the  lungs  from  sham 
group.  As  expected,  the  nuclear  localization  of  p65 
increased  markedly  in  I/R+S,  I/R+V  and  I/R+E 
groups compared with sham group (Fig. 6). As indi-
cated by previous results, p65 expression was signif-
icantly  reduced  by  emulsified  isoflurane  precondi-
tioning, but not by normal saline or lipid vehicle pre-
conditioning (P<0.05).  
 
Figure 4: Effects of emulsified isoflurane pretreatment on TNF-α levels in lung tissue and serum after hepatic I/R 
in rats (n = 8). Compared with sham group, both serum and lung TNF-α levels increased significantly in I/R+S, I/R+V 
and I/R+E groups. Serum and lung TNF-α levels in I/R+E group were significantly lower than those of I/R+S or I/R+V 
group. 
a p<0.01 vs sham group; 
b p <0.05 vs I/R+S group or I/R+V group.  
 
Figure  5:  RT-PCR  analysis  of  ICAM-1  mRNA 
expression in the lung after hepatic I/R (n = 6). 
ICAM-1 mRNA expression was increased markedly 
in I/R+S, I/R+V and I/R+E groups. Compared with 
I/R+S  or  I/R+V  group,  emulsified  isoflurane 
preconditioning  reduced  ICAM-1  mRNA  expres-
sion significantly. 
a p<0.01 vs sham group; 
b p 





Figure 6: Effects of emulsified isoflurane pretreatment on NF-κB p65 translocation in the lung after hepatic I/R 
(n = 3). The top panel shows Western blot analysis for NF-kB p65 in nuclear protein extracts from the rat lung. The 
bottom panel shows relative densitometric units. The average expression level of the sham group data was set to 1.0, 
and other data were adjusted to this baseline. The nuclear localization of p65 increased markedly in I/R+S, I/R+V and 
I/R+E groups compared with sham group, but it was significantly reduced by emulsified isoflurane preconditioning. 
a 
p<0.01 vs sham group; 
b p <0.05 vs I/R+S group or I/R+V group. 
 
Discussion 
Ischemia followed by reperfusion injury is asso-
ciated with a number of clinical disorders, including 
systemic  inflammatory  response  syndrome  (SIRS), 
multiple  organ  dysfunction  syndrome  (MODS)  and 
multiple system organ failure (MOSF). The lung is one 
of  the  most  important  target  organs  in  MODS  or 
MOSF caused by severe injury. It was found that the 
lung could also be damaged by remote organ injury 
such as gut and liver I/R injury22. This process is as-
sociated  with  activation  of  inflammatory  reaction, 
including the increased activity of NF-κB and the in-
creased inflammatory mediators such as TNF-α and 
ICAM-123.  
The  results  of  our  study  showed  that  90-min 
hepatic ischemia followed by 4-h reperfusion induced 
significant lung injury, as manifested by evidence of 
lung  edema,  PMN  infiltration  and  histological  inju-
ries.  Moreover,  lung  injury  was  associated  with  in-
flammation, as indicated by NF-κB translocation, in-
crease  of  TNF-α  levels  and  MPO  activity,  and 
up-regulation of ICAM-1 expression in the lung tis-
sue.  
To  our  knowledge,  this  is  the  first  study 
providing  the  evidence  that  preconditioning  with 
emulsified  isoflurane  could  attenuate  inflammation 
reaction and ALI induced by hepatic I/R. In the study 
we used emulsified isoflurane infused at a rate of 8 
ml·kg-1·h-1 for 30 min, knowing that this dosage had 
no significant inhibitory effect on circulation in pen-
tobarbital  anesthetized  rats  as  shown  by  previous 
experiments24.  Our  results  showed  that  emulsified 
isoflurane preconditioning could reduce lung injury 
induced by hepatic I/R, as represented by decreased 
NF-κB  activity,  TNF-α  level  and  MPO  activity,  and 
decreased ICAM-1 expression in the lung as well. 
Neutrophils are an important component of the 
inflammatory response that characterizes ALI25. Ac-
tivated neutrophils, which infiltrate the lungs during 
endotoxemia,  produce  cytokines,  such  as  interleu-
kin-1β and TNF-α, and play a key role in the devel-
opment of ALI by releasing neutrophil proteases and 
reactive oxygen species26. Previous studies27-29 showed 
that isoflurane preconditioning could reduce neutro-
phil accumulation in the myocardium, and that abol-
ishing neutrophils would induce impairment to con-
tractile function in rat hearts in vitro and in vivo. This 
inhibitory effect of isoflurane on neutrophils was as-
sociated with an inhibition on neutrophil superoxide 
production  and  adherence  to  coronary  vascular  en-




ditioning significantly reduced neutrophil accumula-
tion in the lung, which may be associated with the 
protective effect on the lung. 
Lung injury induced by hepatic I/R is thought of 
as a result of liver-derived TNF-α. In fact, blockade of 
TNF-α  by  antibody  neutralization  greatly  reduced 
hepatic  I/R  induced  lung  inflammatory  injury  in 
rats30.  TNF-α  can  up-regulate  neutrophil  adhesion 
molecules in the liver and remote organs, especially 
intercellular  adhesion  molecule-1  (ICAM-1),  follow-
ing hepatic I/R, which then plays an important role in 
tissue neutrophil influx31.  
Some experiments suggested that ischemic pre-
conditioning  was  able  to  exhibit  anti-inflammatory 
and protective effect in some organs in vitro and in 
vivo.  Isoflurane  could  down-regulate  LPS-induced 
production of pro-inflammatory cytokines, including 
TNF-α and IL-1β in rats32. In this study animals were 
pretreated with 1.4% isoflurane for 30 min before LPS 
injection.  Notably,  isoflurane  inhalation  was  associ-
ated  with  a  significant  reduction  of  endotoxe-
mia-induced pulmonary TNF-α and IL-1β. The simi-
lar protective effect was also observed in a rat model 
of renal I/R injury33. Our results showed that emulsi-
fied  isoflurane  preconditioning  reduced  the  serum 
and lung TNF-α levels and ICAM-1 mRNA expres-
sion in lung tissue after hepatic I/R, which may be at 
least partly contribute to reduced lung injury. 
After  hepatic  ischemia  and  reperfusion,  in-
creased TNF-α level in the circulation initiates a me-
diator cascade in the lung, including neutrophil infil-
tration and increased pulmonary vascular expression 
of  intercellular  adhesion  molecule-1.  The  gene  ex-
pression of these proinflammatory mediators is con-
trolled  at  least  partly  by  the  transcription  factor 
NF-B34. 
NF-B is a key transcription factors that plays a 
key role in inflammatory response and is activated in 
the lung after hepatic IR. Activation of NF-B induced 
expression  of  a  variety  of  inflammation-related 
products,  including  cytokines,  chemokines,  and  ad-
hesion  molecules35,36.  Increased  concentrations  of 
these inflammatory mediators may contribute to lung 
injury.  Previous  studies  showed  that  sevoflurane 
preconditioning and ischemia preconditioning atten-
uated NF-B activation and reduced the expression of 
inflammatory mediators induced by I/R in the heart, 
thus decreasing myocardial IR injury37. It was found 
in  the  present  study  that  emulsified  isoflurane  pre-
conditioning had a similar effect on NF-B transloca-
tion in the lung. Emulsified isoflurane precondition-
ing suppressed the activity of NF-B significantly and 
reduced  the  expression  of  inflammatory  mediators 
including TNF-α and ICAM-1, both of which contrib-
ute to the lung injury after hepatic I/R. 
This study, together with previous reports, sug-
gest that emulsified isoflurane preconditioning could 
ameliorate  lung  edema  and  neutrophil  recruitment, 
decrease TNF-α level in serum and lung tissue, and 
down-regulate  ICAM-1  by  inhibiting  activation  of 
NF-B, which played a key role in inflammatory re-
sponse and is activated in the lung after hepatic IR. 
In  conclusion,  the  present  study  demonstrated 
that emulsified isoflurane may also be protective in 
surgery- or trauma- related organ injuries occurring 
secondary  to  hepatic  I/R.  Emulsified  isoflurane  re-
duced  lung  injury  induced  by  hepatic  I/R,  as  evi-
denced by amelioration of lung edema and neutrophil 
recruitment, decreased TNF-α level in the lung tissue 
and down-regulation of ICAM-1. Zhang et al38 found 
that emulsified isoflurane preconditioning protected 
the  liver  and  lung  in  a  rat  model  of  hemorrhagic 
shock, which might be due to inhibition of cell death 
and improvement of anti-oxidation in mitochondria. 
Rao et al13 found that emulsified isoflurane precondi-
tioning reduced myocardial infarct size, plasma lac-
tate  dehydrogenase  and  creatine  kinase  levels  after 
myocardial  ischemia  reperfusion  in  rats  as  inhaled 
isoflurane. So we speculate that the protective mech-
anism of emulsified isoflurane is generalized and not 
specific to the lung. These results suggest that emul-
sified isoflurane may prove applicable to the clinical 
treatment of organ injury caused by hepatic surgery, 
transplantation or hemorrhagic shock. 
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